Comprehensive Stock Comparison
Compare Concord Medical Services Holdings Limited (CCM) vs HCA Healthcare, Inc. (HCA) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | HCA | 7.1% revenue growth vs CCM's -28.6% |
| Value | CCM | Lower P/E (0.9x vs 17.5x) |
| Quality / Margins | HCA | 9.0% net margin vs CCM's -44.6% |
| Stability / Safety | CCM | Beta 0.25 vs HCA's 0.29 |
| Dividends | HCA | 0.6% yield; 5-year raise streak; CCM pays no meaningful dividend |
| Momentum (1Y) | HCA | +73.9% vs CCM's -29.9% |
| Efficiency (ROA) | HCA | 11.2% ROA vs CCM's -2.4%, ROIC 19.9% vs -7.7% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Concord Medical Services operates a network of radiotherapy and diagnostic imaging centers across China, specializing in cancer treatment services. It generates revenue primarily from operating its network of treatment centers — including linear accelerators and gamma knife systems — and from hospital management services, with additional income from equipment leasing and medical IT services. The company's competitive advantage lies in its established network of specialized cancer treatment facilities across China and its expertise in advanced radiotherapy technologies.
HCA Healthcare is one of the largest for-profit hospital operators in the United States, providing comprehensive medical and surgical services through its network of acute care hospitals and outpatient facilities. It generates revenue primarily from patient services — including inpatient hospital stays, outpatient procedures, and emergency care — with the vast majority coming from government programs like Medicare and Medicaid alongside private insurance reimbursements. The company's scale advantage — operating over 180 hospitals concentrated in high-growth markets — creates significant purchasing power with suppliers and negotiating leverage with payers.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
HCA leads in 4 of 6 categories (Financial Metrics, Profitability & Efficiency). CCM leads in 1 (Valuation Metrics). 1 tied.
Financial Metrics (TTM)
HCA is the larger business by revenue, generating $75.6B annually — 206.7x CCM's $366M. HCA is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to CCM's -44.6%. On growth, HCA holds the edge at +6.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CCMConcord Medical S… | HCAHCA Healthcare, I… |
|---|---|---|
| RevenueTrailing 12 months | $366M | $75.6B |
| EBITDAEarnings before interest/tax | -$359M | $15.5B |
| Net IncomeAfter-tax profit | -$163M | $6.8B |
| Free Cash FlowCash after capex | $0 | $7.7B |
| Gross MarginGross profit ÷ Revenue | -11.4% | +41.5% |
| Operating MarginEBIT ÷ Revenue | -131.0% | +15.8% |
| Net MarginNet income ÷ Revenue | -44.6% | +9.0% |
| FCF MarginFCF ÷ Revenue | -2.1% | +10.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.3% | +6.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +84.0% | +44.6% |
Valuation Metrics
| Metric | CCMConcord Medical S… | HCAHCA Healthcare, I… |
|---|---|---|
| Market CapShares × price | $167M | $118.5B |
| Enterprise ValueMkt cap + debt − cash | $708M | $167.6B |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | 18.66x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.87x | 17.50x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.89x |
| EV / EBITDAEnterprise value multiple | — | 10.82x |
| Price / SalesMarket cap ÷ Revenue | 2.98x | 1.57x |
| Price / BookPrice ÷ Book value/share | 0.00x | — |
| Price / FCFMarket cap ÷ FCF | — | 15.40x |
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), HCA scores 7/9 vs CCM's 3/9, reflecting strong financial health.
| Metric | CCMConcord Medical S… | HCAHCA Healthcare, I… |
|---|---|---|
| ROE (TTM)Return on equity | -9.5% | — |
| ROA (TTM)Return on assets | -2.4% | +11.2% |
| ROICReturn on invested capital | -7.7% | +19.9% |
| ROCEReturn on capital employed | -12.2% | +27.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 |
| Debt / EquityFinancial leverage | 2.43x | — |
| Net DebtTotal debt minus cash | $3.7B | $49.2B |
| Cash & Equiv.Liquid assets | $216M | $1.0B |
| Total DebtShort + long-term debt | $3.9B | $50.2B |
| Interest CoverageEBIT ÷ Interest expense | -2.40x | 5.37x |
Total Returns (with DRIP)
A $10,000 investment in HCA five years ago would be worth $30,878 today (with dividends reinvested), compared to $992 for CCM. Over the past 12 months, HCA leads with a +73.9% total return vs CCM's -29.9%. The 3-year compound annual growth rate (CAGR) favors HCA at 30.2% vs CCM's -36.5% — a key indicator of consistent wealth creation.
| Metric | CCMConcord Medical S… | HCAHCA Healthcare, I… |
|---|---|---|
| YTD ReturnYear-to-date | -14.8% | +12.6% |
| 1-Year ReturnPast 12 months | -29.9% | +73.9% |
| 3-Year ReturnCumulative with dividends | -74.4% | +120.8% |
| 5-Year ReturnCumulative with dividends | -90.1% | +208.8% |
| 10-Year ReturnCumulative with dividends | -92.1% | +688.3% |
| CAGR (3Y)Annualised 3-year return | -36.5% | +30.2% |
Risk & Volatility
CCM is the less volatile stock with a 0.25 beta — it tends to amplify market swings less than HCA's 0.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCA currently trades 95.8% from its 52-week high vs CCM's 33.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CCMConcord Medical S… | HCAHCA Healthcare, I… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.25x | 0.29x |
| 52-Week HighHighest price in past year | $10.77 | $552.90 |
| 52-Week LowLowest price in past year | $3.18 | $295.00 |
| % of 52W HighCurrent price vs 52-week peak | +33.8% | +95.8% |
| RSI (14)Momentum oscillator 0–100 | 41.9 | 56.0 |
| Avg Volume (50D)Average daily shares traded | 7K | 879K |
Analyst Outlook
Wall Street rates CCM as "Buy" and HCA as "Buy". HCA is the only dividend payer here at 0.56% yield — a key consideration for income-focused portfolios.
| Metric | CCMConcord Medical S… | HCAHCA Healthcare, I… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $523.92 |
| # AnalystsCovering analysts | 2 | 46 |
| Dividend YieldAnnual dividend ÷ price | — | +0.6% |
| Dividend StreakConsecutive years of raises | 0 | 5 |
| Dividend / ShareAnnual DPS | — | $2.94 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +8.5% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 20 | Feb 26 | Change |
|---|---|---|---|
| Concord Medical Ser… (CCM) | 100 | 16.67 | -83.3% |
| HCA Healthcare, Inc. (HCA) | 100 | 367.9 | +267.9% |
HCA Healthcare, Inc. (HCA) returned +209% over 5 years vs Concord Medical Ser… (CCM)'s -90%. A $10,000 investment in HCA 5 years ago would be worth $30,878 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Concord Medical Ser… (CCM) | $455M | $384M | -15.6% |
| HCA Healthcare, Inc. (HCA) | $41.5B | $75.6B | +82.2% |
HCA Healthcare, Inc.'s revenue grew from $41.5B (2016) to $75.6B (2025) — a 6.9% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Concord Medical Ser… (CCM) | -57.5% | -80.3% | -39.5% |
| HCA Healthcare, Inc. (HCA) | 7.0% | 9.0% | +28.8% |
HCA Healthcare, Inc.'s net margin went from 7% (2016) to 9% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| HCA Healthcare, Inc. (HCA) | 14.8 | 16.5 | +11.5% |
HCA Healthcare, Inc. has traded in a 12x–17x P/E range over 9 years; current trailing P/E is ~19x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Concord Medical Ser… (CCM) | -1,804.2 | -2,116.8 | -17.3% |
| HCA Healthcare, Inc. (HCA) | 7.3 | 28.38 | +288.8% |
HCA Healthcare, Inc.'s EPS grew from $7.30 (2016) to $28.38 (2025) — a 16% CAGR.
Chart 6Free Cash Flow — 5 Years
Concord Medical Services Holdings Limited generated $-809M FCF in 2024 (+28% vs 2021). HCA Healthcare, Inc. generated $8B FCF in 2025 (+43% vs 2021).
CCM vs HCA: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CCM or HCA a better buy right now?
HCA Healthcare, Inc. (HCA) offers the better valuation at 18.7x trailing P/E (17.5x forward), making it the more compelling value choice. Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CCM or HCA?
On forward P/E, Concord Medical Services Holdings Limited is actually cheaper at 0.9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CCM or HCA?
Over the past 5 years, HCA Healthcare, Inc. (HCA) delivered a total return of +208.8%, compared to -90.1% for Concord Medical Services Holdings Limited (CCM). A $10,000 investment in HCA five years ago would be worth approximately $31K today (assuming dividends reinvested). Over 10 years, the gap is even starker: HCA returned +688.3% versus CCM's -92.1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CCM or HCA?
By beta (market sensitivity over 5 years), Concord Medical Services Holdings Limited (CCM) is the lower-risk stock at 0.25β versus HCA Healthcare, Inc.'s 0.29β — meaning HCA is approximately 18% more volatile than CCM relative to the S&P 500.
05Which has better profit margins — CCM or HCA?
HCA Healthcare, Inc. (HCA) is the more profitable company, earning 9.0% net margin versus -80.3% for Concord Medical Services Holdings Limited — meaning it keeps 9.0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCA leads at 15.8% versus -138.6% for CCM. At the gross margin level — before operating expenses — HCA leads at 41.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is CCM or HCA more undervalued right now?
On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 0.9x forward P/E versus 17.5x for HCA Healthcare, Inc. — 16.6x cheaper on a one-year earnings basis.
07Which pays a better dividend — CCM or HCA?
In this comparison, HCA (0.6% yield) pays a dividend. CCM does not pay a meaningful dividend and should not be held primarily for income.
08Is CCM or HCA better for a retirement portfolio?
For long-horizon retirement investors, HCA Healthcare, Inc. (HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.29), 0.6% yield, +688.3% 10Y return). Both have compounded well over 10 years (HCA: +688.3%, CCM: -92.1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CCM and HCA?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. HCA pays a dividend while CCM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.